Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study
Mateusz Szylberg, Paweł Sokal, Paulina Śledzińska, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2030-2030
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Principles in the Management of Glioblastoma
Domingos Sanchez Roda, Pedro Veiga, Joana Barbosa Melo, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 501-501
Open Access | Times Cited: 17
Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells
Alexander N. Chernov, Alexander Kim, Sofia S. Skliar, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 93, Iss. 5, pp. 455-469
Closed Access | Times Cited: 9
Genetic Prognostic Factors in Adult Diffuse Gliomas: A 10-Year Experience at a Single Institution
Amir Barzegar Behrooz, Hadi Darzi Ramandi, Hamid Latifi‐Navid, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2121-2121
Open Access | Times Cited: 5
A Critical Review on Segmentation of Glioma Brain Tumor and Prediction of Overall Survival
Novsheena Rasool, Javaid Iqbal Bhat
Archives of Computational Methods in Engineering (2024)
Closed Access | Times Cited: 4
Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients
Halka Lhotská, Karolina Janečkova, Hana Cechova, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
MRI radiomics and potential applications to glioblastoma
Grayson W. Hooper, Daniel Thomas Ginat
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Transfer Learning in Cancer Genetics, Mutation Detection, Gene Expression Analysis, and Syndrome Recognition
Hamidreza Ashayeri, Navid Sobhi, Paweł Pławiak, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2138-2138
Open Access | Times Cited: 3
Starting points for the development of new targeted therapies for glioblastoma multiforme
Agnieszka Rusak, Benita Wiatrak, Klaudia Krawczyńska, et al.
Translational Oncology (2024) Vol. 51, pp. 102187-102187
Closed Access | Times Cited: 3
LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models
Ana Podolski-Renić, Margarita Chigriai, Sofija Jovanović Stojanov, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 189-189
Open Access
Positive Prognostic Overall Survival Impacts of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients
Sanjive Qazi, Michael Potts, Scott M. Myers, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1122-1122
Open Access
Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT
Lanlan Zhou, Leiqing Zhang, Jun Zhang, et al.
Oncotarget (2025) Vol. 16, Iss. 1, pp. 230-248
Open Access
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study
Warren Mason, Rebecca A. Harrison, Sarah Lapointe, et al.
Current Oncology (2025) Vol. 32, Iss. 4, pp. 207-207
Open Access
Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma
Valentin Karl Ladenhauf, Malik Galijašević, Johannes Kerschbaumer, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1384-1384
Open Access | Times Cited: 8
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma
Alicia Eckhardt, Richard Drexler, Melanie Schoof, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 3, pp. 503-513
Closed Access | Times Cited: 8
MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma
Erdal Taşçı, Yajas Shah, Sarisha Jagasia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4082-4082
Open Access | Times Cited: 2
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials
Corinna M. Fukushima, John de Groot
Current Opinion in Neurology (2024)
Closed Access | Times Cited: 2
Implications of Advances in Studies of O6-Methylguanine-DNA- Methyltransferase for Tumor Prognosis and Treatment
Yuexia Chen, Wei Qu, Jianhong Tu, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 9
Open Access | Times Cited: 5
Risk factors for preoperative and postoperative seizures in patients with glioblastoma according to the 2021 World Health Organization classification
Anteneh M. Feyissa, Sofía S. Sánchez, Diogo Moniz‐Garcia, et al.
Seizure (2023) Vol. 112, pp. 26-31
Open Access | Times Cited: 5
Effect of radiochemotherapy on peripheral immune response in glioblastoma
Léa Hampe, Susy Daumoine, Emeric Limagne, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 7
Open Access | Times Cited: 1
The mutated in colorectal cancer (MCC) gene can serve as a potential biomarker of glioblastoma
Huonggiang Nguyen, Qingzhi Huang, Uijin Juang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Postoperative NEOadjuvant TEMozolomide followed by chemoradiotherapy vs. upfront chemoradiotherapy for Glioblastoma multiforme (NEOTEM) trial: interim results
Azadeh Sharifian, Ali Kazemian, Mostafa Farzin, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells
Daniel H. Park, Pratik Bhojnagarwala, Kevin Liaw, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009604-e009604
Open Access | Times Cited: 1
The Original M2 And M6 Mouse Models Of Glioblastoma: Morphological And Molecular Characteristics Of Transplanted Tumor Tissue
V. V. Kudelkina, A. I. Alekseeva, A. S. Khalansky, et al.
(2024)
Open Access | Times Cited: 1
Quantification of perineural satellitosis in pretreatment glioblastoma with structural MRI and a diffusion tensor imaging template
Rik van den Elshout, Benthe Ariëns, Joost Blaauboer, et al.
Neuro-Oncology Advances (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Prognostic value of brain perfusion by MRI in the initial study of high grade gliomas
Francisca Fernández‐Valverde, M.P. Bautista-Bárcena, E. Roldán-Romero, et al.
Radiología (English Edition) (2024) Vol. 66, Iss. 2, pp. 114-120
Closed Access
Page 1 - Next Page

Scroll to top